checkAd

     752  0 Kommentare Global ENT and Bronchoscopy Devices Market Expected to Reach $24,999 Million by 2022 - Allied Market Research

    PORTLAND, Oregon and PUNE, India, March 17, 2017 /PRNewswire/ --

    ENT & bronchoscopy devices market was valued at $14,476 million in 2015, and is projected to reach $24,999 million by 2022, growing at a CAGR of 8.1% from 2016 to 2022, According to a new report published by Allied Market Research. The hearing care devices segment accounted for more than two-fifths of the total market in 2015.

         (Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

    Smelling disorders, hearing disorders as well as problems associated with speaking or snoring are rectified by ENT devices. The complete airway of a patient including lungs and alveoli is examined via bronchoscopy. Both ENT & bronchoscopy devices assist otolaryngologists for the treatment of patients suffering from disorders of ear, nose, throat, and related structures of the head & neck.

    Get access to detailed report at: https://www.alliedmarketresearch.com/ent-and-bronchoscopy-market

    The market is driven by high incidence of hearing and nasal disorders, new technological advancements in ENT & bronchoscopy devices, growth in geriatric population, and increase in patient preference for minimally invasive procedures. However, this growth is limited by high cost of these devices (especially in developing nations) and lack of skilled professionals. The demand for cosmetic ENT procedures and emerging markets in Asia-Pacific and LAMEA are expected to provide several opportunities for key players.

    Hearing care devices is expected to maintain its dominant position throughout the analysis period, due to increase in incidence of hearing disorders and technological innovations in hearing devices, such as development of miniature hearing aids, anti-inflammatory drug-releasing cochlear implants, and auditory brainstem implants.

    Surgical ENT & bronchoscopy devices segment is expected to grow at the highest CAGR of 12.5% in the future, owing to increased demand for radiofrequency devices, balloon sinus dilation devices, and ENT lasers.

    According to Hemali Narkhede, Manager, Healthcare Research at Allied Market Research, "There have been revolutionary advancements in ENT & bronchoscopy devices, such as development of smaller hearing aids that are not visible from outside. This has increased the adoption of hearing aids among patients as well as healthcare providers." she further added.

    Seite 1 von 2



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Global ENT and Bronchoscopy Devices Market Expected to Reach $24,999 Million by 2022 - Allied Market Research PORTLAND, Oregon and PUNE, India, March 17, 2017 /PRNewswire/ - ENT & bronchoscopy devices market was valued at $14,476 million in 2015, and is projected to reach $24,999 million by 2022, growing at a CAGR of 8.1% from 2016 to 2022, According to a …